Navigation Links
XTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week
Date:5/7/2008

Webcast to Review CUSTOM III Six-Month Data to be held Tuesday, May 13th

MENLO PARK, Calif., May 7 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT) today announced that six-month follow-up data from the CUSTOM III trial will be presented at EuroPCR, taking place May 13 to 16 in Barcelona. The company will hold a webcast and conference call to review the new CUSTOM III data immediately following the late-breaking session. In addition, two-year CUSTOM I data, previously presented at the Transcatheter Cardiovascular Therapeutics (TCT) meeting last October, has been accepted for publication in the May issue of EuroIntervention. Professor Grube, the CUSTOM I principal investigator, has been asked to present the data during a EuroPCR session on the six best papers from EuroIntervention. XTENT is also sponsoring an evening symposium on customizable drug-eluting stents and will exhibit throughout the meeting at booth E11 in the main hall.

Schedule of XTENT Events for EuroPCR

Tuesday, May 13, 2008, 3:30-6:30 p.m. CEST, Room 1

Late-Breaking Clinical Trial: CUSTOM III trial 6-month follow-up results.

Bernard de Bruyne, M.D., Ph.D, Cardiovascular Center, OLV Hospital in Aalst, Belgium, the principal investigator of the CUSTOM III clinical trial, will present six-month follow-up data from the CUSTOM III trial evaluating use of the Custom NX(R) Drug Eluting Stent (DES) System in patients with long or multiple coronary lesions.

Tuesday, May 13, 2008, 7:00 p.m. CEST (1:00 p.m. EDT)

CUSTOM III webcast and conference call.

To participate in the conference call, please dial 877-591-4957 (from the U.S.) or 719-325-4895 (international). The webcast and slide presentation can be accessed via the in
'/>"/>

SOURCE XTENT, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. XTENT to Present CUSTOM I and CUSTOM II Trial Data at TCT 2007
2. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
3. Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis
4. XTENT Announces First Quarter 2008 Financial Results
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... and PHOENIX , Aug. ... to bring cutting-edge next-generation sequencing and proteomic diagnostics ... today announced a collaboration with TESARO, Inc.  Paradigm ... patient tissue samples from clinical trials to better ... to TESARO,s TSR-011.  This may lead to more successful ...
(Date:8/20/2014)... ApolloDx™ today announced it will unveil and ... event at the company,s office in Salt ... The event, which will start at 10:00 a.m., will ... .    "We believe our mobile diagnostic ... , Co-Founder and Managing Partner of ApolloDx. In addition ...
(Date:8/20/2014)... WORTH, Fla. , Aug. 20, 2014  Glades Drugs, ... , is proud to announce its expansion into a ... , which will feature an 8,000-square-foot office space and state ... currently accepting applications for 100 open positions for the new ... at 4560 Lantana Road will serve as the chain,s corporate ...
Breaking Medicine Technology:Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2
... COGENT-1 Study of CGT-2168 Expands to Europe; Focus ... Gastrointestinal Side Effects of Antiplatelet Therapy, ... Pharmaceuticals,Inc. today announced that the first patient has ... 3 study of its novel combination medicine,CGT-2168. The ...
... Motion Technologies,announced the completion of the first surgical ... System (TM) (TSMS(TM)), the first total,joint replacement system ... and posterior dynamic stabilization device (PDS). The,successful procedure ... Numune,Education and Training Hospital by Dr. Erkan Kaptanoglu, ...
Cached Medicine Technology:European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals 2Disc Motion Technologies Announces First Human Implants of True TSMS(TM) Device 2
(Date:8/20/2014)... 20, 2014 Caddis Partners LLC, has ... any healthcare real estate company in recent years, developing ... valued at $500 million, including more than $100 million ... growth, including expansions into new geographic regions and a ... executives are pleased to announce an enhanced brand identity ...
(Date:8/20/2014)... Biocide Systems is proud to ... as a consultant and partner for a host ... As Wrench Advisors explains on its website, “Our ... plan and execute programs by leveraging Wrench’s access ... experience developing joint venture partnerships and arranging strategic ...
(Date:8/20/2014)... TX (PRWEB) August 20, 2014 The ... Surgery (ACPS), has expanded its presence throughout Houston to ... Mann Eye Institute and Laser Center building. ACPS plastic ... natural step forward for ACPS, which has risen to ... plastic surgery practices in the state since its establishment ...
(Date:8/20/2014)... -- White, straight women are much more likely to ... women, a new study finds. Researchers examined data ... 44, who took part in polls in 2002 and ... Family Growth study. In the first poll, 13 ... for infertility. This ranged from getting advice from doctors ...
(Date:8/20/2014)... survey of U.S. veterans receiving mental health services from ... significant room for improvement among all areas studied. , ... found that patients with a substance use disorder were ... services. Those with substance abuse problems also were less ... them or respected their decisions. , The findings, published ...
Breaking Medicine News(10 mins):Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 2Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 3Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 4Health News:Biocide Systems Announces Partnership with Wrench Advisors 2Health News:Aesthetic Center for Plastic Surgery Expands Its Reach in Texas 2Health News:White Women More Likely to Seek Fertility Treatment: Report 2Health News:Survey finds veterans generally satisfied with mental health care 2
... will present study results that indicate that subconjunctivally delivered ... rat retinas at the Association for Research in Vision ... Fla. The presentation will take place on Thursday, May ... B/C of the Greater Fort Lauderdale/Broward County Convention Center. ...
... to uncover the medium- and large-scale genetic differences between humans ... wide range of diseases, according to a paper by Howard ... in the May 10, 2007, Nature. The undertaking will help ... amount to as much as five to ten percent of ...
... striking similarities between the immune systems of humans and ... could also lead to breakthroughs in the understanding and ... marsupials now found only in the Australian island state ... compiled the full set of genetic information of the ...
... US children undergo some trauma or other early ... post-traumatic stress disorder. ,The finding reveals ... suggests that the way children process troubling experiences is ... Medical Center, whose study appeared in the Archives of ...
... Investigators at St. Jude Children's Research Hospital had a ... kit as it assembled on a double-strand break ... ruptures that cut completely across the twisted, ladder-like structure ... ,Using a technique developed specifically for this project, the ...
... (HCV) are at an increased risk of developing certain ... study published in the May 8, 2007, issue ... from the National Cancer Institute (NCI), part of the ... found that HCV infection increased the risk of developing ...
Cached Medicine News:Health News:Cataloging the Structural Variations in Human Genetics 2Health News:Cataloging the Structural Variations in Human Genetics 3Health News:Treatment of Premature Babies, Opossums Could Help 2Health News:Two-thirds of US Children Experience Trauma, but Recover Fast 2Health News:DNA Repair Proteins Monitored at Double-strand Break 2Health News:Risk of Lymphoma Increases With Hepatitis C Virus Infection 2
0.2 mm hook with curved shaft to reach over lens optic. Flat serrated handle with polished finish. Overall length: 4.8 inches. Most popular size or model....
0.3 mm hook angled 45 degrees, 9 mm from tip to bend. Flat smooth handle with polished finish. Overall length: 4.6 inches....
2.0 mm cup. Angled 45 degree shaft 8 mm from tip to bend with flat handle and polished finish. Overall length: 4.8 inches....
Round, knurled handle with polished finish and straight shaft. 1 mm ring curette 1.5 mm high, 33 mm shaft. Overall length: 5.1 inches....
Medicine Products: